Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
32.36
+0.32 (0.99%)
Oct 14, 2025, 9:32 AM EDT - Market open
Collegium Pharmaceutical Revenue
Collegium Pharmaceutical had revenue of $188.00M in the quarter ending June 30, 2025, with 29.41% growth. This brings the company's revenue in the last twelve months to $707.01M, up 22.61% year-over-year. In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth.
Revenue (ttm)
$707.01M
Revenue Growth
+22.61%
P/S Ratio
1.45
Revenue / Employee
$1,980,412
Employees
357
Market Cap
1.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 631.45M | 64.68M | 11.41% |
Dec 31, 2023 | 566.77M | 102.83M | 22.17% |
Dec 31, 2022 | 463.93M | 187.07M | 67.56% |
Dec 31, 2021 | 276.87M | -33.15M | -10.69% |
Dec 31, 2020 | 310.02M | 13.32M | 4.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
COLL News
- 1 day ago - Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - GlobeNewsWire
- 5 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting - GlobeNewsWire
- 2 months ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewsWire
- 2 months ago - Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 3 months ago - Collegium Announces $150 Million Share Repurchase Program - GlobeNewsWire